US-based contract research and manufacturing organisation ABL is to support the US Army’s $900m medical product research and development (MPRD) programme.
Under a contract awarded by the US Army Medical Research and Materiel Command (MRMC), the company is to provide its comprehensive project management, product development, GMP manufacturing, and testing services for the MPRD project.
The contract has a five-year base period, and includes five additional one-year options.
ABL president and CEO Thomas VanCott said: "The required breadth of product development expertise for the scope of this contract lies within ABL’s core competency.
"With over 50 years of experience conducting biomedical research, as well as manufacturing vaccines and therapeutics for the US Government, ABL provides a unique combination of scientific expertise coupled with operational excellence to address the complex medical issues facing our military today.
"ABL has a proven track record of rapidly assessing highly technical projects and bringing together the right mix of in-house capabilities and external resources to complete mission objectives, and we look forward to contributing to the advancement of critical medical research and products required by the army and other US Department of Defense (DoD) entities."
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Thank you!
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form
By GlobalDataThe company is a member of the Engility Corporation team that recently won the contract to provide chemical, biological, radiological and nuclear (CBRN) support to US military services.